Literature DB >> 15827439

Surgical therapy of hepatocellular carcinoma.

Lucas McCormack1, Henrik Petrowsky, Pierre-Alain Clavien.   

Abstract

There is no worldwide consensus of an algorithm for the radical treatment of hepatocellular carcinoma (HCC). Surgical resection, liver transplantation and, recently, local ablation therapies achieve high curative rates in selected patients. However, recurrence of HCC remains a major problem. This review provides an overview of the current surgical treatment options available for patients with HCC.

Entities:  

Mesh：

Year:  2005        PMID： 15827439     DOI： 10.1097/00042737-200505000-00005

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN： 0954-691X            Impact factor:   2.566


  14 in total

1.  Model for end-stage liver disease exceptions committee activity in Argentina: does it provide justice and equity among adult patients waiting for a liver transplant?

Authors:  Lucas McCormack; Adrián Gadano; Javrer Lendoire; Emilio Quiñonez; Oscar Imventarza; Oscar Andriani; Lorenzo Toselli; Octavio Gil; Gabriel Gondolesi; Liliana Bisigniano; Eduardo De Santibañes
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

2.  Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?

Authors:  Pierre-A Clavien
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

3.  Orthotopic liver transplantation as a rescue operation for recurrent hepatocellular carcinoma after partial hepatectomy.

Authors:  Zhuo Shao; Rocio Lopez; Bo Shen; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

4.  A case of recurrent metastatic hepatocellular cancer controlled with immunotherapy and antiviral therapy following resection.

Authors:  Saadettin Kilickap; Ayse Kars; Erhan Hamaloglu; Halis Simsek
Journal:  Med Oncol       Date:  2009-08-18       Impact factor: 3.064

5.  Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival.

Authors:  Ronnie T P Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; John Wong
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

6.  Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.

Authors:  Stephanie Roessler; Ezhou Lori Long; Anuradha Budhu; Yidong Chen; Xuelian Zhao; Junfang Ji; Robert Walker; Hu-Liang Jia; Qing-Hai Ye; Lun-Xiu Qin; Zhao-You Tang; Ping He; Kent W Hunter; Snorri S Thorgeirsson; Paul S Meltzer; Xin Wei Wang
Journal:  Gastroenterology       Date:  2011-12-24       Impact factor: 22.682

7.  Patient selection for surgical management of primary and metastatic liver cancers: current perspectives.

Authors:  J Alexander Palesty; Mazin Al-Kasspooles; John F Gibbs
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

8.  Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma.

Authors:  Qiang Li; Jian Wang; Jonathan T Juzi; Yan Sun; Hong Zheng; Yunlong Cui; Haixin Li; Xishan Hao
Journal:  J Gastrointest Surg       Date:  2008-07-16       Impact factor: 3.452

9.  Major hepatectomy is a safe modality for the treatment of intrahepatic cholangiocarcinoma in selected patients complicated with cirrhosis.

Authors:  Hao Li; Jin-shu Wu; Xin-tian Wang; Pin Lv; Gang Liu; Bu-ning Tian; Ya-yong Li; Dao-jin Chen; Bo Jiang
Journal:  J Gastrointest Surg       Date:  2013-11-13       Impact factor: 3.452

10.  Outcome of combined hepatocellular and cholangiocarcinoma of the liver.

Authors:  Jue Wang; Fenwei Wang; Anne Kessinger
Journal:  J Oncol       Date:  2010-09-02       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.